The Cancer Therapy & Research Center Institute for Drug Development has been selected to participate in a new clinical trial that involves introducing a living virus into a patient’s system to destroy cancer cells.CTRC is only one of three sites in the Unites States, and the only one in Texas, to be enrolling patients for this new Phase II clinical study for patients with various types of sarcomas that have metastasized to the lung.
